Abstract: A blood glucose test instrument kit having modular component parts capable of being assembled into a plurality of different handheld blood glucose test instruments is disclosed. The kit comprises the combination of an interconnection platform adapted to connect to a collection of interoperable modules. The collection of interoperable modules including: a plurality of different measurement engine modules, at least one user interface module, at least one power supply module. A handheld blood glucose test instrument is assembled by the interconnection to the interconnection platform of at least one measurement engine module, at least one user interface module, and at least one power supply module. The inter-module communication among the modules connected thereto to achieve enhanced glucose test instrument reliability by effecting at least one reliability protocol selected from a group of reliability protocols.

Abstract: A mount for mounting a second structure on a first structure is provided. The mount (100) comprises a housing (10) having a first attachment surface for attachment to the first structure. The mount (100) also includes a biasing member (60) having a first end (62) located within the housing (10). A cupshaped retaining member (22) has a second attachment surface (29) for attaching the retaining member (22) to the second structure, wherein the retaining member (22) is adapted to receive a second end (64) of the biasing member (60) and at least partially locate within the housing (10) such that the biasing member (60) is constrained by the retaining member (22) and the housing (10). A cap (40) surrounds the retaining member (22) and provides a seal between the exterior of the retaining member (22) and the interior of the housing (10).

Abstract: The present application discloses systems and methods for adjusting a back-off value for a rank. In some embodiment, the method includes the steps of: (a) determining whether the rank is underutilized and (b) in response to determining that the rank is underutilized, decreasing the back-off value as a function of time while the rank remains underutilized.

Abstract: The invention provides sterile suspensions and sterile lyophilizates of slightly soluble basic peptide complexes, and pharmaceutical formulations comprising them. The provided sterile suspensions, sterile lyophilizates and pharmaceutical formulations comprising them are particularly suitable for use in a parenteral dosage form as medicaments for the treatment and prophylaxis of diseases and pathological states in mammals, especially in humans.

Abstract: Embodiments of a testing method suitable for diabetic persons to optimize their administered insulin dosage comprise collecting one or more sampling sets of biomarker data, wherein each sampling set comprises a sufficient plurality of non-adverse sampling instances and wherein each sampling instance comprises an acceptable biomarker reading at a single point in time recorded upon compliance with adherence criteria, determining a biomarker sampling parameter from each sampling set, comparing the biomarker sampling parameter to a target biomarker range, calculating an insulin adjustment parameter associated with the biomarker sampling parameter if the biomarker sampling parameter falls outside the target biomarker range, adjusting the insulin dosage by the insulin adjustment parameter if the biomarker sampling parameter falls outside the target biomarker range and if the insulin dosage does not exceed maximum dosage, and exiting the testing method if the adjusted insulin dosage is optimized.

Abstract: The present invention provides a novel process for producing sterile suspensions of slightly soluble basic peptide complexes. The present invention further provides a novel process for producing sterile lyophilizates of slightly soluble basic peptide complexes. In addition, a novel process for producing sterile suspensions suitable for the parenteral administration of slightly soluble basic peptide complexes is provided. The invention moreover provides sterile suspensions and sterile lyophilizates of slightly soluble basic peptide complexes, and pharmaceutical formulations comprising them. The provided sterile suspensions, sterile lyophilizates and pharmaceutical formulations comprising them are particularly suitable for use in a parenteral dosage form as medicaments for the treatment and prophylaxis of diseases and pathological states in mammals, especially in humans.

Abstract: A method is provided for controlling a display device of an electronic device. A data field may be displayed on the display device. An editing process may be executed that provides for editing of the data field displayed on the display device. The data field on the display device may be magnified relative to other portions of the display device when selected for editing according to the editing process.

Abstract: Glucose analysis instrument for diabetics, comprising a measuring device for determining glucose concentration values, a displaying device for displaying glucose concentration values, a signaling device for generating a reminder signal, and a control and evaluation device that comprises a processor and a data memory and is used to determine reminder times at which the signaling device is actuated. Event data are stored in the data memory, the event data containing information on events occurring in the life of a user of the glucose analysis instrument and on the time of occurrence of such events. The reminder times are determined by means of a reminder time determination algorithm taking into consideration event data from at least one previous day.

Abstract: A system for analysing a fluid sample arranged on a test element comprises a data processing unit configured to process results of an analysis of the fluid sample arranged on the test element, an audible signal generator, and a control unit. The control unit may control the audible signal generator to generate an audible test signal that is configured to test the operability of the signal generator to audibly encode information. The audible test signal may include audible features that allow for identification of any deviation of the generated audible test signal from a correctly generated audible test signal, and/or from which malfunction of the signal generator can be detected.

Abstract: A portable analytical device is provided for analysis of a component of a body fluid. A measuring facility within the device may carry out the analysis on a test element inserted therein. The test element may contain a reagent that reacts with a liquid sample of the body fluid when the test element is contacted thereby to produce a change that is characteristic of the analysis. A processor may process measuring values determined by the measuring facility to yield analytical measuring data taking into account calibration values. A standardized, wire-based computer interface may be provided on the analytical device via which the analytical device can be operated by a computer, the analytical measuring data can be transmitted from the analytical device to the computer, the analytical device can be supplied with electrical power by the computer, and the analytical device can provide software to be read-out by the computer.

Abstract: A handheld analysis device for examining a sample of body fluid, such as blood to analyze blood glucose, has a setting mode for changing various device settings to improve the changing of device settings. The handheld analysis device comprises a measurement unit, a microprocessor, a segment display, and an operating element. When the operating element is actuated, the device is placed in a selection mode and further actuation of the operating element, then in one of several setting modes, the user can efficiently change device settings by inputting data and/or control commands.

Abstract: The invention provides sterile suspensions and sterile lyophilizates of slightly soluble basic peptide complexes, and pharmaceutical formulations comprising them. The provided sterile suspensions, sterile lyophilizates and pharmaceutical formulations comprising them are particularly suitable for use in a parenteral dosage form as medicaments for the treatment and prophylaxis of diseases and pathological states in mammals, especially in humans.

Abstract: A process of producing kiwifruit seed oil involves first sterilizing the picked and selected ripe kiwifruit by flame, chlorine wash, or ozone impregnated water wash, followed by a fresh water rinse. The fruit is then cut using a water laser to minimize seed damage. Next the skin is separated from the fruit. Then the pulp is gently separated from the seed ensuring minimal seed coat damage. The resulting seed is cleaned whilst ensuring minimal seed coat damage. Then seed is then dried using cool temperature drying. The seed is stored at a cool temperature until it is needed for oil extraction. Crushing of the seed takes place immediately prior to the super critical extraction process. Super critical extraction using liquid carbon dioxide extracts the kiwifruit oil from the crushed seeds. The oil is the stabilized using a natural antioxidant such as rosemary oil.

Abstract: An electronic device for analysis of a body fluid comprises a housing defining an opening therein, a measuring facility and at least one electrical circuit arranged inside the housing, and a multi-wire connector carried by the housing. The measuring facility is configured to receive a test element therein via the opening and to produce measuring values relating to a sample of the body fluid received on the test element. The at least one electrical circuit is configured to process the measuring values to yield analytical data corresponding to a component of the sample of the body fluid. The multi-wire connector has at least one wire defining a voltage supply input to the electronic device, and is configured to be connected to a mating connector of an external electronic device with the at least one wire configured to receive a supply voltage from the external electronic device.

Abstract: The invention relates to a method for the audible output of a piece of information by an audible signal generator, where the signal generator is arranged in an analysis system and the analysis system analyses a fluid sample using a test element, where analysis results are generated and are processed by a data processing unit, and where a control unit in the analysis system actuates the signal generator, so that the signal generator audibly outputs a piece of information, the signal generator sending an audible test signal in order to test the operability of the signal generator.

Abstract: In particular for the measurement of blood glucose concentrations, portable diagnostic devices are disclosed that are user-friendly and safe to handle. A method is proposed which controls the range of functions of diagnostic devices and avoids incorrect operation of diagnostic devices of this kind, by substantially preventing unintentional and unnoticed alteration of critical parameters, typically system time and/or system date. The method includes a key-recognition step and an enable step. The key-recognition step determines whether at least one key module is connected to the diagnostic device. Depending on whether such a connection exists, the alteration of at least one critical parameter stored and/or generated in the diagnostic device is permitted or prevented in the enable step.

Abstract: Glucose analysis instrument for diabetics, comprising a measuring device for determining glucose concentration values, a displaying device for displaying glucose concentration values, a signaling device for generating a reminder signal, and a control and evaluation device that comprises a processor and a data memory and is used to determine reminder times at which the signaling device is actuated. Event data are stored in the data memory, the event data containing information on events occurring in the life of a user of the glucose analysis instrument and on the time of occurrence of such events. The reminder times are determined by means of a reminder time determination algorithm taking into consideration event data from at least one previous day.

Abstract: The invention generally related to a method and device for displaying the remaining serviceable life of a battery-operated analytical device for analysis of a medically-relevant component of a body fluid, in particular of a blood glucose measuring device.

Abstract: The present invention provides a novel process for producing sterile suspensions of slightly soluble basic peptide complexes. The present invention further provides a novel process for producing sterile lyophilizates of slightly soluble basic peptide complexes. In addition, a novel process for producing sterile suspensions suitable for the parenteral administration of slightly soluble basic peptide complexes is provided. The invention moreover provides sterile suspensions and sterile lyophilizates of slightly soluble basic peptide complexes, and pharmaceutical formulations comprising them. The provided sterile suspensions, sterile lyophilizates and pharmaceutical formulations comprising them are particularly suitable for use in a parenteral dosage form as medicaments for the treatment and prophylaxis of diseases and pathological states in mammals, especially in humans.